相关实验视频
Updated: Jun 10, 2025

05:44
Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
Published on: January 12, 2017
10.0K
复杂脱血治疗方案对乳腺癌相关淋巴的体积和功能的影响:全球影响和预测因素
Tri Tinh Vo1, Paul Bayens1, Chloé Meseeuw1
1Departments of Physical Medicine and Rehabilitation, CHU UCL (Université de Louvain) Namur site Godinne, Yvoir, Belgium.
Lymphatic research and biology
|October 11, 2024
概括
乳腺癌相关淋巴 (BCRL) 的早期复杂脱血疗法 (CDT) 显著减少四肢体积并改善功能. 第一次CDT和较低的初始BCRL体积产生最好的体积减少结果.
科学领域:
- 在瘤学瘤学.
- 康复医学 康复医学 康复医学
- 淋巴 edem 管理 淋巴 edem 管理
背景情况:
- 乳腺癌相关的淋巴 (BCRL) 是影响患者生活质量的常见并发症.
- 复杂脱血疗法 (CDT) 是对淋巴的标准治疗方法.
研究的目的:
- 评估初始和重复的CDT对BCRL体积和患者功能的影响.
- 为了确定预治疗量或之前的CDT会话是否会影响治疗结果.
主要方法:
- 一项前性研究,包括100名单边BCRL.RL患者.
- 进行了499次CDT (6小时/天5天).
- 使用问卷评估肢体体积和国际功能分类 (ICF).
主要成果:
- 在CDT后观察到显著的BCRL体积减少 (50%) 和功能改善 (30%).
- 通过较低的初始BCRL体积 (10%-20%) 和在第一个CDT过程中实现更大的体积减少.
- 无论初始体积或之前的CDT治疗,功能改善都是一致的.
结论:
- 早期和密集的CDT对于有效的BCRL体积控制和功能增强至关重要.
- 第一次CDT和较低的初始淋巴 edem 严重程度与优越的体积减少有关.
相关概念视频
Cardiomyopathy VI: Nursing Management
2
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
2
Heart Failure V: Nursing Interventions
2
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
2
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Mitral Regurgitation IV: Nursing Management
3
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
3
Heart Failure VI: Adjunct Therapies
5
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5
Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2

